Does Rallies show Form 4 insider transactions for LTRN?

Yes. Rallies tracks LTRN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is LTRN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for LTRN. It does not provide personalized investment advice.

LTRN (Lantern Pharma Inc. Common Stock) Stock Analysis - Insider Trades

Lantern Pharma Inc. Common Stock (LTRN) is a publicly traded Healthcare sector company. As of May 21, 2026, LTRN trades at $3.20 with a market cap of $38.28M and a P/E ratio of -2.01. LTRN moved +2.91% today. Year to date, LTRN is -2.46%; over the trailing twelve months it is -8.91%. Its 52-week range spans $1.11 to $6.12. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces LTRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading LTRN stock inside the company?

Recent LTRN insider activity includes Schalop Lee Troy bought 48.54K, KEYSER D JEFFREY bought 48.54K, Fletcher Aaron G.L. sold 7.21K, Fletcher Aaron G.L. sold 12.32K, and Fletcher Aaron G.L. sold 1.90K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

LTRN Key Metrics

Key financial metrics for LTRN
Metric	Value
Price	$3.20
Market Cap	$38.28M
P/E Ratio	-2.01
EPS	$-1.57
Dividend Yield	0.00%
52-Week High	$6.12
52-Week Low	$1.11
Volume	346.43K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-17.12M
Gross Margin	0.00%

Recent LTRN Insider Trades

Schalop Lee Troy bought 48.54K (~$100.00K) on May 12, 2026.
KEYSER D JEFFREY bought 48.54K (~$100.00K) on May 12, 2026.
Fletcher Aaron G.L. sold 7.21K (~$22.27K) on Jun 13, 2025.
Fletcher Aaron G.L. sold 12.32K (~$38.07K) on Jun 13, 2025.
Fletcher Aaron G.L. sold 1.90K (~$5.88K) on Jun 13, 2025.

Latest LTRN News

Lantern Pharma Cuts Costs 19%, Posts $17.1M Net Loss and Secures FDA IND — Apr 3, 2026
Lantern Pharma Secures Third LP-284 Orphan Drug Status and Opens AI Hub — Feb 12, 2026

LTRN Analyst Consensus

1 analysts cover LTRN: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.

Common questions about LTRN

Who is trading LTRN stock inside the company?: Recent LTRN insider activity includes Schalop Lee Troy bought 48.54K, KEYSER D JEFFREY bought 48.54K, Fletcher Aaron G.L. sold 7.21K, Fletcher Aaron G.L. sold 12.32K, and Fletcher Aaron G.L. sold 1.90K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for LTRN?: Yes. Rallies tracks LTRN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is LTRN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for LTRN. It does not provide personalized investment advice.